Central European Journal of Urology最新文献

{"title":"The effect of ureteral double J stent insertion on work performance in patients undergoing endoscopic stone treatment.","authors":"Muhammed Emin Polat, Mustafa Karaaslan, Mehmet Yilmaz, Erkan Olcucuoglu, Mehmet Emin Sirin","doi":"10.5173/ceju.2023.110","DOIUrl":"https://doi.org/10.5173/ceju.2023.110","url":null,"abstract":"<p><strong>Introduction: </strong>Despite the developments in the material of the double J (DJ) stents and the production of thinner ones of desired sizes, patients continue to experience troublesome DJ stent-related symptoms in their lives. This study aimed to determine how DJ stenting affects patients' work performance after endoscopic stone surgery.</p><p><strong>Material and methods: </strong>A total of 107 patients underwent placement of a ureteral stent after ureterorenoscopy (URS)/retrograde intrarenal surgery (RIRS), and only active and full-time working patients were included. All patients were asked to complete the validated Turkish version of the work performance score (WPS) questionnaire in the Ureteral Stent Symptom Questionnaire (USSQ) the day before stent removal and again one month after stent removal.</p><p><strong>Results: </strong>Of the participants, 32.7% (n = 35) were female and 67.3% (n = 72) were male; the mean age was 41 (19-80) years. The workday loss had no statistically significant correlation with patient BMI, stone size, or stent indwelling time (p >0.005); however, a statistically significant negative correlation was detected with patient age (r = -0.335, p <0.001). The medians of WPSs with the stent and without the stent were 6 (3-15) and 3 (3-12), respectively (p <0.001).</p><p><strong>Conclusions: </strong>Although DJ catheterization is a crucial tool for urological practice, it may increase the social and economic burden of patients due to reduced work performance and lost workdays. Therefore, limiting the duration of the DJ stent's stay and providing treatments to minimize patient symptoms will positively impact their professional lives. It would be beneficial to avoid DJ stenting in routine practice unless medically necessary.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 1","pages":"117-121"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retrograde intrarenal surgery using the ILY robotic flexible ureteroscope: a single centre experience.","authors":"Jan Łaszkiewicz, Wojciech Krajewski, Łukasz Nowak, Joanna Chorbińska, Francesco Del Giudice, Aleksandra Sójka, Małgorzata Mazur, Szymon Pisarski, Wojciech Tomczak, Bartosz Małkiewicz, Tomasz Szydełko","doi":"10.5173/ceju.2023.228","DOIUrl":"https://doi.org/10.5173/ceju.2023.228","url":null,"abstract":"<p><strong>Introduction: </strong>The ILY robotic flexible ureteroscope has been introduced in order to improve intraoperative ergonomics, reduce operator distance from radiation and shorten the learning curve. In this study we aimed to assess the clinical performance and feasibility of the ILY robot during retrograde intrarenal surgery (RIRS) and combined endoscopic procedures (miniECIRS).</p><p><strong>Material and methods: </strong>The RIRS procedures were performed using the ILY robotic arm in 57 adult patients (46 RIRS and 11 miniECIRS) from 2022 to 2023. All procedures were performed in the supine position. Pre-stenting was not the standard of care.</p><p><strong>Results: </strong>Turning on and calibration of the device took approximately 100 s. Average draping time was 93 s using original ILY drapes and 47 s using classic drapes designed for C-arm covering. Mean docking time was 73 s in procedures with ureteral access sheath (UAS) and 61 s in procedures without it. The undocking took less than 60 s in every case. Average procedure time was 63 min for RIRS and 55 min for miniECIRS. Endoscopically proven stone-free rate was achieved in 37 (80.4%) RIRS and 10 (90.9%) miniECIRS patients. A total of 17 (36.9%) RIRS and 8 (72.7%) miniECIRS procedures required conversion in order to perform basketing and stone fragments retrieval/transposition.</p><p><strong>Conclusions: </strong>The use of ILY robot during endourological procedures is feasible and urologists that are familiar with the device controller do not require extensive training. The time needed for device draping, docking and undocking was approximately 4 minutes. Moreover, use of the robot resulted in satisfactory stone-free rates.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 1","pages":"136-139"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Regional versus general anaesthesia in percutaneous nephrolithotomy: a systematic review and meta-analysis.","authors":"Mohammed Shahait, Tuan Thanh Nguyen, Nguyen Xuong Duong, Philip Mucksavage, Bhaskar K Somani","doi":"10.5173/ceju.2023.233","DOIUrl":"https://doi.org/10.5173/ceju.2023.233","url":null,"abstract":"<p><strong>Introduction: </strong>Several studies have compared the safety and effectiveness of general and regional anaesthesia in percutaneous nephrolithotomy (PCNL). This study aimed to compare the perioperative and postoperative outcomes of general anaesthesia and regional anaesthesia for patients undergoing PCNL.</p><p><strong>Material and methods: </strong>For relevant articles, three electronic databases, including PubMed, Scopus, and Web of Science, were searched from their inception until March 2023. A meta-analysis has been reported in line with PRISMA 2020 and AMSTAR Guidelines. The risk ratio (RR) and mean difference (MD) were applied for the comparison of dichotomous and continuous variables with 95% confidence intervals (CI).</p><p><strong>Results: </strong>The final cohort analysis, comprised 3871 cases of PCNL, (2154 regional anaesthesia and 1717 general anaesthesia). Compared to general anaesthesia, the regional anaesthesia group had a significantly shorter length of stay (MD = -0.34 days, 95% CI -0.56 to -0.12, p = 0.002), lower postoperative nausea and vomiting rates (RR = 0.16, 95% CI 0.03 to 0.80, p = 0.026), lower complications grade III-V rates (RR = 0.68, 95% CI 0.53 to 0.88, p = 0.004), and lower postoperative visual analogue pain score (VAS) at 1 hour (MD = -3.5, 95% CI -4.1 to -2.9, p <0.001). There were no significant differences in other outcomes between the two groups.</p><p><strong>Conclusions: </strong>Our results show that PCNL under regional anaesthesia is safe and feasible, with comparable results to those done under general anaesthesia. While patient selection is important, counselling and decision-making for these procedures must go hand in hand to achieve the best clinical outcome.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 1","pages":"140-151"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Extracorporeal shock wave lithotripsy, ureterolithotripsy, and percutaneous nephrolithotripsy challenges in managing spinal cord neuropathy patients. Lessons learned from a scoping review.","authors":"Daniele Castellani, Carlo Brocca, Demetra Fuligni, Carlo Giulioni, Angelo Antezza, Angelo Cormio, Arianna Rubino, Lucia Pitoni, Virgilio De Stefano, Giulio Milanese, Luigi Cormio, Bhaskar Kumar Somani, Vineet Gauhar, Andrea Benedetto Galosi","doi":"10.5173/ceju.2023.123","DOIUrl":"https://doi.org/10.5173/ceju.2023.123","url":null,"abstract":"<p><strong>Introduction: </strong>We aim to review the outcomes of shock wave lithotripsy (SWL), ureteroscopy, and percutaneous nephrolithotripsy (PCNL) for renal and ureteral stones in spinal cord neuropathy patients (SNP).</p><p><strong>Material and methods: </strong>A literature search was performed on 8^th March 2023 using PubMed, EMBASE, and Google Scholar with no date limit. Preclinical/animal studies, reviews, letters to the editor, case reports, and meeting abstracts were excluded. Only English papers were accepted.</p><p><strong>Results: </strong>Thirty-five articles were accepted. Five studies focused on SWL, 17 on PCNL, and 6 on ureteroscopy. The remaining articles employed more than one procedure. Stone composition has shifted from struvite to the more common calcium phosphate. SWL showed a very poor stone-free rate (SFR) likely due to challenges in patient positioning, stone visualization, localization, and inability to pass fragments spontaneously. Flexible ureteroscopy and PCNL were associated with a high incidence of infectious complications, long hospital stays, high blood transfusion rate, and intensive care admissions. There were also cases of death. Both procedures were challenging due to genitourinary reconstruction, scoliosis and kyphosis, rib-cage deformity, lower limb contractures, and severe comorbidity which also affected anesthesia. SFR was lower than in non-neurological patients.</p><p><strong>Conclusions: </strong>SWL, ureterolithotripsy, and PCNL should be considered challenging procedures in SNP due to positioning issues, an increased risk of intra and peri-operative morbidity, and even mortality. Computed tomography should be recommended to assess residual fragments as it becomes imperative to minimize a re-intervention in SNP who should be preferably treated in referral centers.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 1","pages":"89-110"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140847414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Penile urethrostomy for recurrent long-segment strictures of the penile urethra: step-by-step surgical technique.","authors":"Leonidas Karapanos, Luisa Halbe, Axel Heidenreich","doi":"10.5173/ceju.2023.158","DOIUrl":"https://doi.org/10.5173/ceju.2023.158","url":null,"abstract":"","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 1","pages":"157-158"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictors of biochemical recurrence after robot-assisted radical prostatectomy: single-centre analysis.","authors":"Umberto Carbonara, Constantinos Adamou, Danny Darlington Carbin, Dimitrios Papadopoulos, Gerasimos Fragkoulis, Danielle Whiting, Murthy Kusuma, James Hicks, Dimitrios Moschonas, Krishna Patil, Matthew James Alexander Perry, Wissam Abou Chedid","doi":"10.5173/ceju.2023.187","DOIUrl":"https://doi.org/10.5173/ceju.2023.187","url":null,"abstract":"<p><strong>Introduction: </strong>We evaluated risk factors for biochemical recurrence (BCR) after robot-assisted radical prostatectomy (RARP) based on our department database.</p><p><strong>Material and methods: </strong>Patients who underwent RARP between 2018 and 2020 were identified and included in our retrospective study. Patients who received neoadjuvant treatment, patients with positive lymph nodes, salvage prostatectomies, and patients with missing data were excluded. BCR was defined as PSA ≥0.2 ng/ml. Parameters that were investigated were the International Society of Urological Pathologists (ISUP) score, stage, and positive surgical margins (PSM) as they were reported in the pathology report. A subgroup analysis based on the tumour stage was performed.</p><p><strong>Results: </strong>A total of 414 patients were included in the analysis. Seventy-seven of them experienced BCR. Based on multivariable analysis, ISUP grade was a strong predictor for BCR with odds ratio (OR): 2.86 (CI: 1.49-5.65; p = 0.002), OR: 5.90 (CI: 1.81-18.6; p = 0.003), OR: 4.63 (CI: 1.79-11.9; p = 0.001) for ISUP grade 3, 4, 5, respectively. Regarding tumour stage, pT2 and pT3a did not show any significant difference in predicting BCR (p = 0.11), whereas pT3b stage was a predictor for BCR with OR: 6.2 (CI: 2.25-17.7; p < 0.001). In the subgroup analysis for 206 patients with pT2 disease, ISUP group and PSM were predictors for BCR. On the other hand, when patients with pT3 disease were inspected, the only parameter that was predictive of BCR was pT3b disease (OR: 4.68, CI: 1.71-13.6; p = 0.003). ISUP grade, the extent of T3 disease, and the extent and ISUP grade of surgical margins were not predictors of BCR.</p><p><strong>Conclusions: </strong>The most important risk factors for BCR after RARP are ISUP grade and tumour stage. In pT2 disease, PSM is a significant predictor of BCR, along with high ISUP grade. The substage pT3b can be considered a predictor of BCR in pT3 cases.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 2","pages":"189-195"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The temporary impact of COVID-19 on semen deoxyribonucleic acid fragmentation.","authors":"Mykola Kvach, Oleg Nikitin, Andriy Kost, Oleg Banyra","doi":"10.5173/ceju.2024.263","DOIUrl":"https://doi.org/10.5173/ceju.2024.263","url":null,"abstract":"<p><strong>Introduction: </strong>Coronavirus disease 2019 (COVID-19) is characterized by impact on different systems of human body. Recently, several anti-COVID vaccines have been developed.</p><p><strong>Material and methods: </strong>In our study, we included two groups of males: GROUP1, anti-COVID vaccinated males, n = 46, and GROUP2, n = 43, non-vaccinated males, who all fell ill with the Coronavirus infection. A level of semen DNA fragmentation was characterized by Sperm DNA Fragmentation Index (SDFI) that was calculated before infection and compared with data at every month after laboratory recovery. The Mann-Whitney test was used to establish differences between parameters, with p <0.05 considered significant.</p><p><strong>Results: </strong>Compared with the pre-COVID baseline we registered significant increasing of SDFI in each group of participants: 35.3 ±4.7% vs 18.6 ±5.8% in GROUP1, p = 0.0009, and 41.8 ±5.6% vs 19.2 ±6.1% in GROUP2, p = 0.0006. At the 2^nd month after recovery SDFI in GROUP1 and GROUP2 continued to grow and reached its peak to 40.6 ±6.4% and 49.7 ±7.2% respectively. Thereafter SDF indexes in both Groups started to decrease, normalizing at the 7^th month after COVID-19 recovery in GROUP1 and at the 9^th month in GROUP2.</p><p><strong>Conclusions: </strong>COVID-19 causes a gradual increase in semen DNA fragmentation, which peaks at the 2^nd month after recovery and is more pronounced in unvaccinated men. Normalization of SDFI occurs no earlier than at the 7^th month in vaccinated and at the 9^th month in non-vaccinated men.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 2","pages":"298-303"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bilateral robotic nephrectomy using a supine robotic approach without repositioning through 8-18 mm incisions in a young female with focal and segmental glomerulosclerosis: a video case report.","authors":"Luca Antonelli, Adrian Duss, Leutrim Zahiti, Agostino Mattei, Christian Daniel Fankhauser","doi":"10.5173/ceju.2024.26","DOIUrl":"https://doi.org/10.5173/ceju.2024.26","url":null,"abstract":"","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 2","pages":"344-345"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Body mass index, obesity and risk of prostate cancer: a systematic review and meta-analysis.","authors":"Fajar Gemilang Ramadani, Noor Riza Perdana, David Ralph Lienhardt Ringoringo","doi":"10.5173/ceju.2023.162","DOIUrl":"https://doi.org/10.5173/ceju.2023.162","url":null,"abstract":"<p><strong>Introduction: </strong>Prostate cancer (PCa) is one of the most diagnosed cancer in male. Body mass index (BMI) has been linked to the risk of cancer and its mortality. Our objective was to undertake a quantitative analysis elucidating the relationship between BMI and the risk of PCa.</p><p><strong>Material and methods: </strong>A literature search was conducted in PubMed, ProQuest, and EMBASE using relevant keywords and phrases. BMI was classified as underweight (BMI <18.5 kg/m²), normal (18.5-25 kg/m²), overweight (25-30 kg/m²), and obese (>30 kg/m²). We used random-effect model to assess relative risk (RR) of PCa incidence and mortality.</p><p><strong>Results: </strong>A total of 13 studies were included in quantitative analysis. Underweight patients exhibited a decreased risk of PCa compared to those with normal weight (RR: 0.44; 95% CI 0.04-5.08; p = 0.51). Higher BMI has been associated with higher risk of PCa among overweight patients (RR: 1.08; 95% CI 1.06-1.11; p <0.00001) and obese patients (RR: 1.12; 95% CI 1.07-1.17; p <0.00001) respectively. The combined analysis of overweight and obese individuals also indicated a heightened risk of PCa (RR: 1.02; 95% CI 1.04-1.11; p <0.0001). Mortality rates were higher in overweight and obese individuals, though not statistically significant (RR 1.15; 95% CI 0.88-1.52; p = 0.31).</p><p><strong>Conclusions: </strong>BMI >25 kg/m² was associated with an increased risk of prostate cancer and mortality.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 2","pages":"176-188"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of botulinum toxin in the management of refractory de novo overactive bladder symptoms in women after midurethral sling placement: retrospective, single center study.","authors":"Sameh Hijazi, Leonidas Karapanos, Luisa Halbe, Axel Heidenreich, Viktoria Hasselhof, Bara Barakat, Pavlo Synoverskyy","doi":"10.5173/ceju.2023.273","DOIUrl":"https://doi.org/10.5173/ceju.2023.273","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed o evaluate the efficacy of onabotulinumtoxin A (onaBTX-A) intradetrusor injections in women with refractory de novo overactive bladder (OAB) following midurethral sling (MUS) placement.</p><p><strong>Material and methods: </strong>A retrospective single-center study was conducted. We screened 372 women who underwent MUS surgery between August 2009 and January 2022. 54/372 women diagnosed with pharmacologically refractory de novo OAB following MUS were evaluated using cystoscopy and urodynamics, and after tape erosion and obstructive voiding were excluded, they received onaBTX-A therapy. Outcomes were the reduction of self-reported OAB symptoms and leakage episodes, improvement of validated OAB scores and adverse events of the procedure after a follow-up of 3, 6, and 12 months.</p><p><strong>Results: </strong>Successful results were reported in 81%, 68%, and 43% at 3, 6 and 12 months respectively. Postoperatively, median voiding frequency and median nocturia episodes were significantly improved in 70% and 77% of women, respectively, with a decrease in daily number of voids (-4.1, p = 0.0001) and nocturia episodes (-2.2, p = 0.005). At 3 months, 80% of women reported an >25% reduction in urgency severity and episodes following injection. The median number of pads used was significantly reduced after injection (-2 pads; p = 0.03). Repeat injections of onaBTX-A were performed in 61% of patients after a median of 11 months.</p><p><strong>Conclusions: </strong>Intravesical onaBTX-A injections are clinically effective at 3- and 6-month follow-up for the treatment of refractory de novo OAB after MUS placement. Over 60% of the patients opted for retreatment with onaBTX-A due to a high level of satisfaction.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"77 2","pages":"213-217"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11428366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}